In Vitro Diagnostics: Archives News of the month
Distribution and antifungal susceptibility profiles of Candida species isolated from candidemia patients admitted to Egyptian tertiary hospitals: a cross-sectional study
In Vitro Diagnostics 4 min.
Candida species constitute a major part the microflora of the human skin, mucous membranes, and digestive tract [1]. However, Candida can cause mild or severe infections in humans and is being a notable cause of bloodstream infection (BSI) [2, 3]. The risk factors for Candida...
Characterization of Candida species isolated from clinical specimens: insights into virulence traits, antifungal resistance and molecular profiles
In Vitro Diagnostics 4 min.
Fungal infections affect over one billion people and cause about 1.5 million deaths annually. The lack of effective diagnostics and treatments, along with rising antifungal resistance, exacerbates the problem. At-risk patients include those with cancer, diabetes, HIV, and those using antibiotics,...
Combined NGS and lung biopsy for refractory respiratory failure: a case of HRV and secondary bacterial pneumonia mimicking organizing pneumonia
In Vitro Diagnostics 5 min.
Recent studies have indicated that viruses account for 29–55% of community-acquired pneumonia (CAP) cases among adults, and the most common virus detected is human rhinovirus (HRV) (4.9 ∼ 30.6%) [1, 2–3]. HRV is also reported as the most frequently detected respiratory virus...
Genome analyses of colistin-resistant high-risk blaNDM-5 producing Klebsiella pneumoniae ST147 and Pseudomonas aeruginosa ST235 and ST357 in clinical settings
In Vitro Diagnostics 9 min.
The antibiotic development pipeline has run dry, failing to compete with the constantly evolving antimicrobial resistance (AMR) crisis [1]. This ‘silent pandemic’ led to approximately 5 million mortalities in 2019 and is predicted to escalate drastically in 2050 with 10 million annual deaths...
